Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment
Authors not listed
Centre Hospitalier de Saint-Denis · 2022
Abstract
This study aims to better understand Alzheimer's disease by looking at brain scans, specifically MRI images, to detect early signs of brain changes linked to the disease. Researchers are focusing on the hippocampus, a part of the brain that shrinks in people with Alzheimer's. The study will also explore other brain changes that often happen alongside hippocampal shrinkage. By analyzing these brain images, the study hopes to find ways to diagnose Alzheimer's earlier and more accurately using advanced imaging techniques.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Anonymous. (2022). Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment. <em>Centre Hospitalier de Saint-Denis</em>. https://clinicaltrials.gov/study/NCT06965816
Vancouver
Anonymous. Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment. Centre Hospitalier de Saint-Denis. 2022.
BibTeX
@misc{anon2022UsingN,
title = {Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment},
author = {Anonymous},
journal = {Centre Hospitalier de Saint-Denis},
year = {2022},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Neurobiology of Disease 2014
Preprint · OA
Early detection of Alzheimer's disease using PiB and FDG PET
Neurobiology of Aging 2012
Preprint · OA
Neuroinflammatory phenotype in early Alzheimer's disease
Seoul National University Hospital 2014
Open access · US-GOV
Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's Disease
US Department of Veterans Affairs 1999
Open access · US-GOV
Insulin, Neurogenetics and Memory in Alzheimer's Disease: A Novel Therapeutic Approach
Ascentys Ltd 2023
Open access · US-GOV
Feasibility Study for the Use of Computer Game Technology in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Acta Neuropathologica 2003
Citation only